课题基金 / 基金详情

Tailored inhibitory control training to reverse EA-linked deficits in mid-life

Tailored inhibitory control training to reverse EA-linked deficits in mid-life
定制的抑制控制训练可扭转中年与 EA 相关的缺陷
批准号:
8797794
负责人:
Elliot Todd Berkman
金额:
$29.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-30 至 2015-04-30

项目摘要

项目成果

Elliot Todd Berkman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Early adversity (EA) in humans is a major contributing factor to a range of deleterious physical and mental health outcomes extending through adulthood such as depression and anxiety, obesity and heart disease, and premature death. In addition to detracting significantly from individual well-being and quality of life, these conditios also consume considerable resources from federal, state, and community organizations. The mechanisms through which EA exerts its effects on these outcomes are increasingly well understood, and include neurocognitive pathways related to executive function. An intervention that can successfully target, engage with, and alter the functioning of one or more of these mechanisms would be a promising way of mitigating the impact of EA on deleterious outcomes later in life. The proposed research focuses on one such pathway-deficits in inhibitory control (IC)-and tests the feasibility and efficacy of an intervention to increase functioning in that pathway in a sample of individuals who experienced EA. The intervention is grounded in a neurally informed model of change that specifies deficits in IC as an underlying causal factor common to several health-risking behaviors (HRBs). These IC deficits emerge during development as a result of a range of EA, and, critically, can be remediated in mid-life through targeted intervention. Research from our laboratory has validated an intervention that can increase IC performance and alter its underlying neural systems in young adults (Berkman, Kahn, & Merchant, 2014). The next step in this program of research, proposed here, is to test the efficacy of that intervention in a sample of mid-life individuals who have experienced EA and the extent to which our intervention generalizes to HRBs that are prevalent in that sample. The first Aim is to test whether the intervention alters the IC system in tasks both similar to and dissimilar from the training task in terms of both behavioral performance and neural functioning. The second Aim is to test whether alterations in the functioning of the underlying neural systems mediate the effect of the intervention on performance and The two Aims will be accomplished within the context of a single RCT with two arms (IC training vs. active control) and pre-post measurements of IC performance, IC neural systems, and HRBs. All participants (N = 110) come to the lab for an initial assessment of behavioral / neural measures of IC and HRBs, among other measures. Then, participants are randomly assigned to receive a Person-Centered Inhibitory Control (PeCIC) training or active control training, every other day for 3-4 weeks. The PeCIC systematically pairs IC engagement with alcohol, tobacco, and/or energy-dense food cues, depending on each participant's reports of disinhibited behavior in those domains. The active control task uses personalized cues and response time tasks but does not involve IC. Finally, participants return to the laboratory for an endpoint assessment where all baseline measures are repeated. The two Aims will be robustly tested in a series of analyses comparing the behavioral and neural change from pre- to post-intervention between the groups disinhibition-related HRBs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Construal level as a novel pathway for affect regulation and cancer control
  • 批准号:
    9909179
  • 项目类别:
  • 资助金额:
    $61.02万
  • 财政年份:
    2020
  • 负责人:
    Elliot Todd Berkman
  • 依托单位:
Construal level as a novel pathway for affect regulation and cancer control
  • 批准号:
    10666142
  • 项目类别:
  • 资助金额:
    $9.28万
  • 财政年份:
    2020
  • 负责人:
    Elliot Todd Berkman
  • 依托单位:
Construal level as a novel pathway for affect regulation and cancer control
  • 批准号:
    10371037
  • 项目类别:
  • 资助金额:
    $58.24万
  • 财政年份:
    2020
  • 负责人:
    Elliot Todd Berkman
  • 依托单位:
Construal level as a novel pathway for affect regulation and cancer control
  • 批准号:
    10807262
  • 项目类别:
  • 资助金额:
    $14.34万
  • 财政年份:
    2020
  • 负责人:
    Elliot Todd Berkman
  • 依托单位:
海外基金